Legrand; Valerie

Patent Applications and Registrations

Patent applications and USPTO patent grants for Legrand; Valerie.The latest application filed is for "oral pharmaceutical compositions with controlled release and prolonged absorption".

Company Profile

0.6.8

Legrand; Valerie - Lyons FR
Legrand; Valerie - Strasbourg FR
Legrand; Valerie - Lyon FR
Legrand; Valerie - Illkirch Graffenstaden FR
Legrand; Valerie - Yerres FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles Grant 8,101,209 - Legrand , et al. January 24, 2	2012-01-24
Oral pharmaceutical compositions with controlled release and prolonged absorption Grant 7,879,362 - Castan , et al. February 1, 2	2011-02-01
Modified adenovirus fibre and uses Grant 7,560,527 - Legrand , et al. July 14, 2	2009-07-14
Oral pharmaceutical compositions with controlled release and prolonged absorption App 20070207214 - Castan; Catherine ; et al.	2007-09-06
Modified adenoviral fiber and target adenoviruses Grant 7,256,036 - Legrand , et al. August 14, 2	2007-08-14
Modified adenoviral fiber with ablated to cellular receptors App 20060228334 - Rosa-Calatrava; Manuel ; et al.	2006-10-12
Microcapsules for the delayed, controlled release of perindopril App 20060165808 - Huet De Barochez; Bruno ; et al.	2006-07-27
Galenic microparticulate oral formulation for delayed and controlled release of pharmaceutical active principles App 20050037077 - Legrand, Valerie ; et al.	2005-02-17
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles App 20040234601 - Legrand, Valerie ; et al.	2004-11-25
Modified adenoviral fibre and uses thereof Grant 6,740,511 - Van Raaij , et al. May 25, 2	2004-05-25
Modified adenoviral fiber and uses App 20040038205 - Van Raaij, Mark Johan ; et al.	2004-02-26
Oral pharmaceutical composition with controlled release and prolonged absorption App 20040022849 - Castan, Catherine ; et al.	2004-02-05
Modified adenoviral fiber and target adenoviruses App 20030175243 - Legrand, Valerie ; et al.	2003-09-18
Modified adenoviral fiber and target adenoviruses Grant 6,569,677 - Legrand , et al. May 27, 2	2003-05-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.